Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Amneal to expand manufacturing operations in US
The facility enlargements and resulting jobs increase will generate an estimated $21 million per year in additional payroll and other benefits to local economies, according to the company.
The facility enlargements and resulting jobs increase will generate an estimated $21 million per year in additional payroll and other benefits to local economies, according to the company.
NBTXR3, a nanoparticle formulation of hafnium oxide crystals, is designed for the local treatment of tumors. Under the agreement, Nanobiotix will receive an upfront payment of $1m and
All products will contain ProBiora3, the Company’s patented proprietary blend of three probiotics purposely designed for oral health. Oragenics president and CEO John Bonfiglio said the agreement reinforces
The launch of the Montelukast Sodium Tablets indicated for treating symptoms of asthma and allergic rhinitis follows the expiration of the last patent that provides Merck US market
The company expects to transfer research functions at Urogenix to Astellas’ Tsukuba Research Center in Japan. The closure of the North Carolina-based urology research facility, which at present
The patients in the SWOG S1106 mantle cell lymphoma trial will undergo testing for MRD during treatment and for up to three years of clinical follow up using
PhRMA and AG are analyzing the costs associated with the post-approval trials, identifying cost drivers and variations. The research will leverage negotiated clinical costs from Medidata Grants Manager
As part of the agreement, Chiesi will distribute the product in Europe, Turkey and former CIS countries including promoting the drug, identifying patients and handling reimbursements. Kamada will
The product has been developed by Schoeller-Bleckmann Medizintechnik (SBM), a subsidiary of Bosch Packaging Technology. SBM general manager Alfred Kaliwoda said the systems achieve an availability of up
The assay will offer stand-alone test in conjunction with a new comprehensive prognostic profiling panel for patients with chronic lymphocytic leukemia (CLL). The CLL Profile panel also includes